Tyler-Stone Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-31
Closed -$6.31K – 666
2024
Q2
$6.31K Hold
31
– – ﹤0.01% 716
2024
Q1
$6.77K Hold
31
– – ﹤0.01% 709
2023
Q4
$7.05K Hold
31
– – ﹤0.01% 686
2023
Q3
$6K Sell
31
-5
-14% -$1.05K ﹤0.01% 688
2023
Q2
$7K Buy
+36
New +$6.98K ﹤0.01% 668
2022
Q4
$7K Sell
36
-21
-37% -$4.1K ﹤0.01% 612
2022
Q3
$10K Hold
57
– – 0.01% 536
2022
Q2
$11K Sell
57
-6
-10% -$1.28K 0.01% 537
2022
Q1
$14K Hold
63
– – 0.01% 520
2021
Q4
$17K Buy
+63
New +$15.6K 0.01% 509

Other funds holding LH

Tyler-Stone Wealth Management's LH Position: Q3 2024 in Review

Tyler-Stone Wealth Management sold out of Labcorp (LH) in Q3 2024, closing a stake of 31 shares — an estimated $6.31K sold.

Tyler-Stone Wealth Management first reported a position in LH in Q4 2021 and held it in 10 quarters. The position peaked at $17K in Q4 2021. 920 funds tracked by Wall St. Rank hold LH as of Q3 2024.

  • Tyler-Stone Wealth Management reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
  • Tyler-Stone Wealth Management sold 31 Labcorp shares in Q3 2024, an estimated $6.31K.
  • Tyler-Stone Wealth Management first reported a position in Labcorp in Q4 2021 and held it in 10 quarters.
  • Tyler-Stone Wealth Management's Labcorp position peaked at $17K in Q4 2021.
  • 920 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Tyler-Stone Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.